Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription


2 Biol Psychiatry
2 J Nerv Ment Dis
2 Mol Psychiatry
1 Neuropsychopharmacology
1 PLoS One
1 Proc Natl Acad Sci U S A
4 Psychiatry Res
1 Psychol Med
15 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Biol Psychiatry

  1. PAUL SM, Yohn SE, Brannan SK, Neugebauer NM, et al
    Muscarinic Receptor Activators as Novel Treatments for Schizophrenia.
    Biol Psychiatry. 2024 Mar 25:S0006-3223(24)01173.
    PubMed         Abstract available

  2. GONZALEZ-PENAS J, Alloza C, Brouwer R, Diaz-Caneja CM, et al
    Accelerated Cortical Thinning in Schizophrenia is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders.
    Biol Psychiatry. 2024 Mar 21:S0006-3223(24)01170.
    PubMed         Abstract available

    J Nerv Ment Dis

  3. TONDEHAL N, Sengupta A, Mohankumar K, Trivedi C, et al
    Mixed Connective Tissue Disease Presenting With Psychosis-A Case Report.
    J Nerv Ment Dis. 2024;212:235-239.
    PubMed         Abstract available

  4. RIDENOUR JM, Hamm JA, Wiesepape CN, Buck B, et al
    Restoring Trust for People With Psychosis Through Psychotherapy.
    J Nerv Ment Dis. 2024;212:228-234.
    PubMed         Abstract available

    Mol Psychiatry

  5. CHEN S, Tan Y, Tian L
    Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
    Mol Psychiatry. 2024 Mar 26. doi: 10.1038/s41380-024-02539.
    PubMed         Abstract available

  6. KOSKUVI M, Porsti E, Hewitt T, Rasanen N, et al
    Genetic contribution to microglial activation in schizophrenia.
    Mol Psychiatry. 2024 Mar 22. doi: 10.1038/s41380-024-02529.
    PubMed         Abstract available


  7. SCHOONOVER KE, Dienel SJ, Holly Bazmi H, Enwright JF 3rd, et al
    Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia.
    Neuropsychopharmacology. 2024 Mar 28. doi: 10.1038/s41386-024-01854.
    PubMed         Abstract available

    PLoS One

  8. LIU J, Sun SJ, Lu Y, Ping X, et al
    Taste dysfunction as a predictor of depression in schizophrenia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0300935.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  9. HALL NT, Hallquist MN, Martin EA, Lian W, et al
    Automating the analysis of facial emotion expression dynamics: A computational framework and application in psychotic disorders.
    Proc Natl Acad Sci U S A. 2024;121:e2313665121.
    PubMed         Abstract available

    Psychiatry Res

  10. YANG H, Zhu D, Liu Y, Xu Z, et al
    Employing graph attention networks to decode psycho-metabolic interactions in Schizophrenia.
    Psychiatry Res. 2024;335:115841.
    PubMed         Abstract available

  11. SETHI S, Wakeham D, Ketter T, Hooshmand F, et al
    Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial.
    Psychiatry Res. 2024;335:115866.
    PubMed         Abstract available

  12. SEFIK E, Guest RM, Aberizk K, Espana R, et al
    Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Psychiatry Res. 2024;335:115867.
    PubMed         Abstract available

  13. GALLEGO JA, McNamara RK, Blanco EA, Castaneda S, et al
    Evidence for cytokine dysregulation in schizophrenia spectrum disorders: A comparison of cerebrospinal fluid and blood samples.
    Psychiatry Res. 2024;335:115871.
    PubMed         Abstract available

    Psychol Med

  14. DENG L, Wei W, Qiao C, Yin Y, et al
    Dynamic aberrances of substantia nigra-relevant coactivation patterns in first-episode treatment-naive patients with schizophrenia.
    Psychol Med. 2024 Mar 25:1-11. doi: 10.1017/S0033291724000655.
    PubMed         Abstract available

    Schizophr Res

  15. GAO YN, Wang R, Gu G, Chung R, et al
    Inpatient antipsychotic medication switching and rehospitalization risk among patients with schizophrenia-spectrum disorders.
    Schizophr Res. 2024;267:165-172.
    PubMed         Abstract available

  16. YU B, Sun Z, Li S, Chien IC, et al
    Social isolation and cognitive function in patients with schizophrenia: A two years follow-up study.
    Schizophr Res. 2024;267:150-155.
    PubMed         Abstract available

  17. BENNETT ME, Medoff D, Cowan T, Fang L, et al
    Tobacco smoking and nicotine vaping in persons with first episode psychosis.
    Schizophr Res. 2024;267:141-149.
    PubMed         Abstract available

  18. PELIZZA L, Leuci E, Leucci AC, Quattrone E, et al
    Diagnostic shift in first episode psychosis: Results from the 2-year follow-up of the "Parma Early Psychosis" program.
    Schizophr Res. 2024;267:99-106.
    PubMed         Abstract available

  19. MEHTA DD, Siddiqui S, Ward HB, Steele VR, et al
    Functional and structural effects of repetitive transcranial magnetic stimulation (rTMS) for the treatment of auditory verbal hallucinations in schizophrenia: A systematic review.
    Schizophr Res. 2024;267:86-98.
    PubMed         Abstract available

  20. LHO SK, Kim T, Moon SY, Kim M, et al
    Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis.
    Schizophr Res. 2024;267:130-137.
    PubMed         Abstract available

  21. ZHOU R, Ye M, OuYang X, Zhang S, et al
    Insomnia and aggression in stable schizophrenic patients: The mediating role of quality of life.
    Schizophr Res. 2024;267:122-129.
    PubMed         Abstract available

  22. ELAM HB, Perez SM, Donegan JJ, Eassa NE, et al
    Knockdown of Lhx6 during embryonic development results in neurophysiological alterations and behavioral deficits analogous to schizophrenia in adult rats.
    Schizophr Res. 2024;267:113-121.
    PubMed         Abstract available

  23. EL HAJ M, Raffard S, Besche-Richard C
    Decoding schizophrenia: ChatGPT's role in clinical and neuropsychological assessment.
    Schizophr Res. 2024;267:84-85.

  24. NAIR N, Xavier S, Rabouin D, Mohan G, et al
    Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Canada.
    Schizophr Res. 2024;267:75-83.
    PubMed         Abstract available

  25. ARSLAN B, Kizilay E, Verim B, Demirlek C, et al
    Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders.
    Schizophr Res. 2024;267:65-71.
    PubMed         Abstract available

  26. OZER D, Dissiz M
    The effect of online group based acceptance and commitment therapy on psychotic symptoms and functioning levels of individuals with early psychosis.
    Schizophr Res. 2024;267:55-64.
    PubMed         Abstract available

  27. MELVIN E, Green M, Keiller E, Parmar C, et al
    A systematic review of dramatherapy interventions used to support adults with psychosis.
    Schizophr Res. 2024;267:44-54.
    PubMed         Abstract available

  28. TZARTOS J, Karagiorgou K, Pechlivanidou M, Tzartos S, et al
    Absence of neuronal nicotinic acetylcholine receptor antibodies in sera and CSF from schizophrenia patients.
    Schizophr Res. 2024;267:39-41.

  29. KETCHAM E, Schooler NR, Severe JB, Buckley PF, et al
    Longitudinal study of insomnia, suicidal ideation, and psychopathology in schizophrenia.
    Schizophr Res. 2024;267:34-38.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.